The Promises and Limitations of Artificial Intelligence for Population Health in Diabetes.

Abstract

Get full access to this article

View all access options for this article.

References

World Health Organisation, Diabetes Fact Sheet, 10 November 2021. https://www.who.int/news-room/fact-sheets/detail/diabetes, Accessed Jan 07, 2022.

Centers for Disease Control and Prevention, National Diabetes Statistics Report, 2021. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf, Accessed Jan 07, 2022.

Dennis

, Young

, McGovern

, Mateen

, Vollmer

, Simpson

, Henley

, Holman

, Sattar

, Pearson

, Hattersley

, Jones

, Shields

. (2021). Derivation and validation of a type 2 diabetes treatment selection algorithm for SGLT2-inhibitor and DPP4-inhibitor therapies based on glucose-lowering efficacy: cohort study using trial and routine clinical data. Article in pre-print. medRxiv 2021.11.11.21265959; doi: https://doi.org/10.1101/2021.11.11.21265959 Accessed Jan 03, 2022.

Barts Health NHS Trust News, AI technology at Barts Life Sciences spares at-risk diabetic patients from limb amputation. 21 August 2021. https://www.bartshealth.nhs.uk/news/ai-technology-at-barts-health-spares-atrisk-diabetic-patients-from-limb-amputation-11289. Accessed Jan 05, 2022.

National Institute of Diabetes and Digestive and Kidney Diseases, Artificial Pancreas, October 2021. https://www.niddk.nih.gov/health-information/diabetes/overview/managing-diabetes/artificial-pancreas Accessed Dec 20, 2021.